GC
BIIB icon

GMT Capital’s Biogen BIIB Stock Holding History

GMT Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-38,650
Closed -$8.14M – 91
2022
Q1 		$8.14M Sell
38,650
-5,200
-12% -$1.13M 0.51% 36
2021
Q4 		$10.5M Hold
43,850
– – 0.81% 25
2021
Q3 		$12.4M Sell
43,850
-3,100
-7% -$1.02M 1.09% 21
2021
Q2 		$16.3M Sell
46,950
-14,620
-24% -$4.43M 1.21% 20
2021
Q1 		$17.2M Sell
61,570
-12,600
-17% -$3.4M 1.27% 18
2020
Q4 		$18.2M Sell
74,170
-5,200
-7% -$1.34M 1.29% 19
2020
Q3 		$22.5M Sell
79,370
-51,500
-39% -$14.4M 1.64% 18
2020
Q2 		$35M Sell
130,870
-160,100
-55% -$48.1M 1.97% 15
2020
Q1 		$92.1M Buy
290,970
+13,600
+5% +$4.13M 5.17% 4
2019
Q4 		$82.3M Buy
277,370
+18,280
+7% +$5.07M 3.18% 9
2019
Q3 		$60.3M Sell
259,090
-48,230
-16% -$11.2M 2.23% 12
2019
Q2 		$71.9M Sell
307,320
-63,340
-17% -$14.6M 2.51% 10
2019
Q1 		$87.6M Buy
370,660
+6,290
+2% +$1.98M 2.9% 8
2018
Q4 		$110M Buy
364,370
+20,820
+6% +$6.64M 4.08% 7
2018
Q3 		$121M Sell
343,550
-16,850
-5% -$5.8M 3.15% 8
2018
Q2 		$105M Buy
360,400
+36,000
+11% +$10.1M 2.49% 9
2018
Q1 		$88.8M Buy
324,400
+5,300
+2% +$1.65M 2.12% 13
2017
Q4 		$102M Buy
319,100
+26,000
+9% +$8.34M 2.07% 13
2017
Q3 		$91.8M Buy
293,100
+40,900
+16% +$12.1M 1.84% 15
2017
Q2 		$69.1M Buy
252,200
+31,600
+14% +$8.36M 1.48% 20
2017
Q1 		$60.3M Buy
220,600
+22,700
+11% +$6.42M 1.27% 29
2016
Q4 		$56.1M Buy
197,900
+4,510
+2% +$1.34M 1.17% 30
2016
Q3 		$60.5M Sell
193,390
-1,510
-0.8% -$447K 1.24% 26
2016
Q2 		$47.1M Buy
194,900
+24,900
+15% +$6.56M 1.14% 30
2016
Q1 		$44.3M Buy
170,000
+139,400
+456% +$36.8M 1.09% 29
2015
Q4 		$9.37M Buy
+30,600
New +$8.79M 0.24% 68

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GMT Capital's BIIB Position: Q2 2022 in Review

GMT Capital sold out of Biogen (BIIB) in Q2 2022, closing a stake of 38,650 shares — an estimated $8.14M sold.

GMT Capital first reported a position in BIIB in Q4 2015 and held it in 26 quarters. The position peaked at $121M in Q3 2018. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • GMT Capital reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • GMT Capital sold 38,650 Biogen shares in Q2 2022, an estimated $8.14M.
  • GMT Capital first reported a position in Biogen in Q4 2015 and held it in 26 quarters.
  • GMT Capital's Biogen position peaked at $121M in Q3 2018.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on GMT Capital's 13F filing for Q2 2022, filed 10 Aug 2022.